RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,739,421 | -32.4% | 801,358 | +0.9% | 0.00% | -50.0% |
| Q2 2023 | $9,975,504 | -30.6% | 794,228 | -9.0% | 0.00% | -33.3% |
| Q1 2023 | $14,368,790 | +9.0% | 872,422 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $13,181,488 | -27.9% | 882,295 | +7.9% | 0.00% | -25.0% |
| Q3 2022 | $18,294,000 | +36.7% | 817,835 | +2.4% | 0.00% | +33.3% |
| Q2 2022 | $13,383,000 | -31.2% | 798,949 | +22.8% | 0.00% | 0.0% |
| Q1 2022 | $19,464,000 | -7.4% | 650,351 | -5.0% | 0.00% | 0.0% |
| Q4 2021 | $21,018,000 | +15.8% | 684,390 | +18.8% | 0.00% | 0.0% |
| Q3 2021 | $18,158,000 | -5.0% | 575,928 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $19,104,000 | +24.4% | 522,106 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $15,355,000 | +3.8% | 444,133 | +24.8% | 0.00% | 0.0% |
| Q4 2020 | $14,791,000 | -3.0% | 355,893 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $15,249,000 | – | 358,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |